It connects patients with independent providers who can prescribe FDA-approved GLP-1 medications including Wegovy, Zepbound, and Foundayo, if clinically appropriate, with program fees starting at $59 a month and medication billed separately
They are approved only for type 2 diabetes and obesity management, and clinical evidence for IBD treatment remains extremely limited with no completed randomized controlled trials
CareCredit also offers reduced APR fixed payment plans: 17.90% for 24 months, 18.90% for 36 months, 19.90% for 48 months, and 20.90% for 60 months
It does well at blocking hunger
Beyond retatrutide, other pharmaceutical companies are also working on next-gen therapies (including oral pills that mimic these injectables, and even combinations targeting four hormones)